What Henry Meds does

Henry Meds, operated by Adonis Health, Inc. (a Delaware corporation), is a direct-to-consumer telehealth platform founded in 2022 that connects adult patients with licensed healthcare providers for remote consultation and prescription services. The platform is organized around four clinical verticals: weight management (compounded GLP-1 medications including injectable and oral semaglutide, oral tirzepatide, liraglutide, and phentermine, plus a Microdose program), women's hormone replacement therapy (estrogen and progesterone in tablets, patches, and creams, with optional testosterone cream), men's testosterone replacement therapy (injectable testosterone cypionate, topical cream, enclomiphene, or oral KYZATREX), and erectile dysfunction treatment (oral PDE-5 inhibitors and intracavernous Trimix/Bimix/Quadmix injections). The core technology stack is a telehealth platform that handles online medical intake, provider matching, video consultation, secure messaging, and prescription routing to fulfillment partners.

The business model is a self-pay, subscription-based cash-pay model with no insurance participation. Plans bundle provider visits, medication, supplies, and shipping at monthly prices ranging from $50 (oral ED) to $297 (injectable GLP-1), with 6-month and 12-month prepay options carrying meaningful discounts. A $30 non-refundable medical consultation fee is charged when a prescription is issued. Medications are compounded and dispensed through partnerships with licensed U.S. 503A and 503B compounding pharmacies and shipped directly to patients, while laboratory testing is coordinated through Quest Diagnostics with hybrid at-home collection via Tasso+ devices. Marketing is asset-light and DTC, relying on Trustpilot reviews, referral and affiliate programs with tracked codes, and content marketing. The company operates from Las Vegas, Nevada with an additional office in Katowice, Poland, and is supported by early-stage capital from Heron Rock Fund (2022). Compliance posture includes HIPAA, CCPA, and LegitScript certification.

Name

Henry Meds

Legal name

Adonis Health, Inc.

Website

https://henrymeds.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

251–500 employees

Short description

Henry Meds is a direct-to-consumer telehealth platform connecting adults with licensed providers for weight management (compounded GLP-1s), women's HRT, men's TRT, and ED treatment via subscription cash-pay plans with home-delivered compounded medications.

Ownership category

akta.pro rank

Product category

Telehealth Healthcare Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)

akta.pro secondary industry

Primary Care & General Medicine Virtual Care (HLALAAAA)

Keywords

• Telehealth services
• Weight management treatment
• Hormone replacement therapy
• Compounded medications
• Direct-to-consumer healthcare

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Subscription Plans: Monthly subscription plans bundling provider consultations, prescribed medications, supplies, and shipping. Plans range from $50/month (oral ED) to $297/month (semaglutide injections). Multi-month plans offer discounts (6-month and 12-month options). A $30 non-refundable medical consultation fee is charged when a prescription is issued.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Henry Meds is a direct-to-consumer telehealth platform that connects patients with licensed healthcare providers for personalized treatment of chronic conditions, including weight management (GLP-1 medications), hormone replacement therapy (women's HRT and men's TRT), and erectile dysfunction therapy. Prescribed compounded medications are fulfilled by licensed U.S. compounding pharmacies and shipped directly to patients' homes on a self-pay, all-inclusive monthly subscription basis without requiring insurance.

Product overview

Henry Meds is a telehealth platform offering personalized, affordable healthcare across four core verticals: Weight Management, Women's Hormone Replacement Therapy (HRT), Testosterone Replacement Therapy (TRT), and Erectile Dysfunction (ED) treatment. The platform operates as a unified service connecting patients with licensed healthcare providers through telehealth consultations, with prescribed medications fulfilled by licensed compounding pharmacies and shipped directly to patients. The Weight Management program includes multiple GLP-1 medication options (semaglutide, tirzepatide, liraglutide) in both injectable and oral forms, plus phentermine. The HRT and TRT programs provide hormone therapies with various delivery methods. The ED program offers both oral PDE-5 inhibitors and injectable ICP medications (Bimix, Trimix, Quadmix). All services include provider visits, medication, supplies, and ongoing care in subscription pricing with no insurance required.

Differentiator

Problem solved

Functional benefit

Products and services

• GLP-1 Weight Management Program Monthly subscription program pairing patients with licensed providers for personalized weight management treatment using compounded GLP-1 medications dispensed by U.S. compounding pharmacies and shipped to patients' homes.
• Compounded Semaglutide Injection Compounded injectable semaglutide (GLP-1 agonist) dispensed for weight management patients enrolled in the Henry Meds subscription program.
• Compounded Semaglutide Oral Dissolvable Tablets Oral dissolvable tablet form of compounded semaglutide offered as an alternative for weight management patients who prefer oral delivery.
• Compounded Tirzepatide Oral Dissolvable Tablets Compounded tirzepatide in oral dissolvable tablet form dispensed for weight management patients enrolled in the Henry Meds subscription program.
• Compounded Liraglutide Injection Compounded injectable liraglutide (GLP-1 agonist) dispensed for weight management patients enrolled in the Henry Meds subscription program.
• Phentermine Weight Management Program Weight management program using oral phentermine prescriptions for eligible patients seeking an alternative to GLP-1 medications.
• Women's Hormone Replacement Therapy (HRT) Program Monthly subscription program connecting women with licensed providers for personalized hormone replacement therapy, with compounded medications shipped to the patient's home.
• Men's Testosterone Replacement Therapy (TRT) Program Monthly subscription program pairing male patients with licensed providers for testosterone replacement therapy, including compounded testosterone medications delivered to the home.
• Erectile Dysfunction (ED) Treatment Program Monthly subscription program providing telehealth consultations and compounded ED medications to male patients seeking discreet treatment of erectile dysfunction.
• ICP Injections Intracavernosal Pharmacotherapy injections offered as a treatment option for erectile dysfunction patients.

Quantifiable outcome

• Patients lost approximately 18% of body weight in a year using injectable semaglutide through Henry Meds

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Licensed U.S. Compounding Pharmacies (503A/503B)coreTechnology or IntegrationHenry Meds partners with licensed U.S. compounding pharmacies operating under 503A and 503B regulations to prepare customized medications tailored to individual patient needs. These pharmacies dispense medications directly to patients as prescribed by Henry Meds providers.
• Quest DiagnosticscoreTechnology or IntegrationQuest Diagnostics provides laboratory testing services for Henry Meds patients, including at-home collection options via Quest facilities or through hybrid solutions like Tasso+ self-collection devices.
• American Arbitration Association (AAA)minorOthersAAA administers arbitration proceedings for dispute resolution under the consumer arbitration rules and consumer due process protocol, as specified in the terms of service.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Ro: DTC telehealth company operating in weight management (including compounded GLP-1s through Ro Pharmacy), men's health, and women's health on a cash-pay subscription model. Direct overlap with Henry Meds' core verticals and pharmacy-fulfillment approach.
• Noom Med: Subsidiary of Noom offering clinician-supervised GLP-1 weight management on a cash-pay monthly subscription. Directly overlaps with Henry Meds' GLP-1 weight management program and shares the cash-pay chronic-condition positioning.
• LifeMD: Subscription-based telehealth platform offering weight management (including compounded semaglutide via subsidiary), men's hormone therapy, women's HRT, and ED treatment. Operates on a similar cash-pay subscription model with vertically integrated pharmacy.
• BlueChew: DTC telehealth subscription service for oral erectile dysfunction medications (sildenafil/tadalafil) on a cash-pay monthly model. Directly comparable to Henry Meds' ED oral offering on price, channel, and customer profile.
• Sesame: DTC telehealth marketplace offering weight loss (including GLP-1 programs), men's and women's health, and primary care on cash-pay pricing. Competes with Henry Meds on the cash-pay chronic-condition patient with similar self-pay positioning.
• RedBox Rx: DTC telehealth platform offering ED, hair loss, and weight management on cash-pay subscription pricing. Directly comparable subscription model and cash-pay chronic-condition positioning to Henry Meds.
• Hims & Hers Health: Publicly traded DTC telehealth platform offering weight loss (GLP-1s), men's health (TRT, ED), women's health (HRT), and hair/skin care on a subscription cash-pay model. Closest direct competitor to Henry Meds across all four product verticals with materially larger scale and brand reach.

Emerging players

• PlushCare: Telehealth primary care and weight management platform offering GLP-1 treatment via insurance and cash-pay options. Adjacent competitor in Henry Meds' weight management vertical with broader primary care scope.
• Alpha Hormones: Specialty telehealth clinic focused on testosterone replacement therapy, men's hormone optimization, and weight management with cash-pay subscription pricing. Directly overlaps with Henry Meds' TRT and weight management verticals, smaller scale.

Others

• Quest Diagnostics: National clinical laboratory partner of Henry Meds providing lab testing services (including via Tasso at-home collection). Enabler in Henry Meds' HRT/TRT service delivery rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/henry-meds

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Henry Meds